Immix Biopharma, Inc. IMMX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Immix Biopharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s quick ratio?
- Immix Biopharma, Inc. (IMMX) reported quick ratio of 8.8× in Q1 2026.
- How has Immix Biopharma, Inc.'s quick ratio changed year-over-year?
- Immix Biopharma, Inc.'s quick ratio increased by 385.6% year-over-year, from 1.8× to 8.8×.
- What is the long-term trend for Immix Biopharma, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s quick ratio has grown at a 150.8% compound annual growth rate (CAGR), from 0.1× to 10×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.